To further verify whether NF-κB has a role in NSCLC cell migration, A549 and H1299 cells were treated with a potent inhibitor of NF-κB, caffeic acid phenethyl ester (CAPE), and cell migration was determined. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.